Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127419511 | 12741951 | 1 | I | 20160907 | 20160914 | 20160914 | EXP | GB-MYLANLABS-2016M1039054 | MYLAN | SEYWRIGHT A, TORRANCE HJ, WYLIE FM, MCKEOWN DA, LOWE DJ, STEVENSON R. ANALYSIS AND CLINICAL FINDINGS OF CASES POSITIVE FOR THE NOVEL SYNTHETIC CANNABINOID RECEPTOR AGONIST MDMB-CHMICA. CLIN-TOXICOL-(PHILA) 2016;54(8):632-637. | 0.00 | Y | 0.00000 | 20160914 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127419511 | 12741951 | 1 | PS | DIAZEPAM. | DIAZEPAM | 1 | Unknown | U | U | 70325 | |||||||||
| 127419511 | 12741951 | 2 | SS | NORDAZEPAM | NORDAZEPAM | 1 | Unknown | U | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127419511 | 12741951 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127419511 | 12741951 | Confusional state | |
| 127419511 | 12741951 | Dissociative disorder | |
| 127419511 | 12741951 | Sinus tachycardia | |
| 127419511 | 12741951 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |